A Common Finding That Does Not Have One Meaning
Uterine fibroids—also called myomas or leiomyomas—are benign growths arising from the muscular wall of the uterus. They are common during the reproductive years and may be discovered during an ultrasound performed for bleeding, pain, pregnancy planning, or infertility.
Finding a fibroid does not automatically explain infertility.
Some fibroids distort the uterine cavity and may interfere with implantation or pregnancy. Others grow toward the outside of the uterus and may have little reproductive significance. Some cause heavy bleeding, anaemia, pressure, or pain even when fertility is unaffected. Many cause no symptoms at all.
The clinically important questions are therefore not simply, “Is there a fibroid?” or “How large is it?”
At Jinemed, evaluation asks where the fibroid is located, whether it changes the uterine cavity, what symptoms it causes, how it relates to the patient’s reproductive plan, and whether intervention is more likely to help than to delay.
Location Usually Matters More Than the Word “Fibroid”
Fibroids are often described by their relationship to the uterine cavity and outer uterine surface.
Submucosal fibroids project into the uterine cavity. Even when relatively small, they may alter the space where an embryo implants.
Intramural fibroids lie mainly within the muscular wall. Some distort the cavity; others do not.
Subserosal fibroids project toward the outside of the uterus and generally have less direct contact with the endometrial cavity.
Some fibroids cross more than one location. A lesion may be largely intramural but have a submucosal component, or may be attached by a stalk.
Size remains relevant, but a diameter alone is not enough. A smaller fibroid that distorts the cavity may matter more for fertility than a larger fibroid growing outward.
The imaging report should therefore describe location, relationship to the cavity, number, dimensions, and any uncertainty—not simply state “multiple fibroids.”
Symptoms and Fertility Need Separate Assessment
Fibroids can be associated with:
- Heavy or prolonged menstrual bleeding
- Iron-deficiency anaemia
- Pelvic pressure or fullness
- Menstrual or non-menstrual pain
- Urinary frequency or bowel pressure
- Abdominal enlargement
- Infertility or pregnancy complications in selected cases
The treatment that best controls bleeding may not be the treatment that best preserves fertility. Some hormonal medicines reduce bleeding but prevent conception while being used. Some procedures are appropriate for symptom control in patients who have completed childbearing but are unsuitable for someone planning pregnancy.
The first consultation should identify the immediate priority:
- Is the patient trying to conceive now?
- Is bleeding causing anaemia or medical instability?
- Is pain or pressure significantly affecting daily life?
- Is IVF being considered because of another fertility factor?
- Are embryos already cryopreserved?
- Is the fibroid incidental or likely to change treatment?
A fertility plan should not ignore serious symptoms. Symptom treatment should not unintentionally close or postpone reproductive options without discussion.
Imaging Must Answer a Clinical Question
Transvaginal ultrasound is often the first imaging method used to evaluate fibroids. It can describe the uterus, endometrium, ovaries, fibroid size, and general location.
When the relationship to the uterine cavity is unclear, additional evaluation may include:
- Saline-infusion sonography
- Three-dimensional ultrasound
- Diagnostic hysteroscopy
- Magnetic resonance imaging in selected complex cases
Each method answers a different question.
Saline imaging or hysteroscopy may clarify whether a fibroid enters the cavity. MRI can help map numerous, very large, or surgically complex fibroids and distinguish other uterine conditions in selected patients.
More imaging is not automatically better. A test should be requested because its result may change observation, surgery, fertility treatment, or obstetric planning.
For international patients, access to the original images can be as important as the written report. The term “intramural fibroid” may hide whether the cavity is actually distorted.
Cavity-Distorting Fibroids Have the Strongest Fertility Relevance
Among fibroid types, those that distort the endometrial cavity have the clearest association with reduced reproductive potential.
A submucosal fibroid or an intramural fibroid with a submucosal component may alter the implantation environment, interfere mechanically with the cavity, or contribute to bleeding and uterine contractility.
For asymptomatic patients with cavity-distorting fibroids, myomectomy may be considered to improve the chance of pregnancy. Hysteroscopic removal of an accessible submucosal fibroid has evidence supporting improvement in clinical pregnancy rates, although evidence for every later outcome is less certain.
This does not mean every small cavity irregularity requires immediate surgery.
The decision still depends on:
- Degree of distortion
- Fibroid type and depth within the wall
- Size and number
- Symptoms
- Previous pregnancy and treatment history
- Surgical complexity
- Age and fertility timeline
- Whether embryos are already available
The presence of a clearer indication does not remove the need for proportionate counselling.
Non-Cavity-Distorting Intramural Fibroids Remain a Difficult Decision
Intramural fibroids that do not visibly distort the cavity create one of the most debated decisions in fertility care.
Some studies suggest that larger or multiple intramural fibroids may reduce implantation or live-birth outcomes. Other evidence is inconsistent, partly because studies use different size thresholds, imaging methods, patient groups, and definitions of cavity involvement.
There is no universally reliable diameter at which every non-cavity-distorting intramural fibroid should be removed before IVF.
The decision may consider:
- Fibroid size and growth pattern
- Distance from the endometrium
- Number and total uterine burden
- Whether the uterine cavity has been assessed adequately
- Symptoms and anaemia
- Previous implantation or pregnancy history
- Expected difficulty and scar from surgery
- Age, ovarian reserve, and the cost of delaying treatment
- Whether egg collection can proceed before uterine surgery
For an asymptomatic patient, myomectomy is generally not advised solely to improve fertility when fibroids do not distort the cavity. Selected circumstances may justify a different plan, but the reason should be explicit.
Uncertainty is not a reason to operate automatically. It is a reason to discuss the trade-off honestly.
Subserosal Fibroids Usually Do Not Require Removal for Fertility Alone
Subserosal fibroids grow toward the outside of the uterus. They may cause pressure, pain, distortion of surrounding anatomy, or technical problems when very large, but they generally have less direct effect on the endometrial cavity.
Evidence does not support removing an asymptomatic subserosal fibroid solely to improve pregnancy outcomes.
Surgery may still be indicated for significant symptoms, rapid or concerning change, compression of other structures, uncertainty in diagnosis, or severe anatomical distortion. In IVF, a very large fibroid may occasionally affect ovarian access or pelvic anatomy.
The indication should match the problem being treated. “Improving fertility” should not be used as a general justification when the likely benefit is symptom relief or technical access.
Not Every Infertility Case with Fibroids Is Fibroid Infertility
Fibroids are common enough to coexist with other causes of infertility.
A complete evaluation may still need to consider:
- Age-related egg quality
- Ovarian reserve
- Ovulation
- Tubal function
- Semen factors
- Endometriosis or adenomyosis
- Endometrial polyps or adhesions
- Previous pregnancy and miscarriage history
Removing a fibroid cannot correct an unrelated male factor, restore age-related egg competence, or reverse diminished ovarian reserve.
Before recommending surgery, the team should ask whether the fibroid is the most plausible limiting factor and whether another issue makes delay particularly important.
The operation should not become a substitute for completing the fertility assessment.
Hysteroscopic Myomectomy Treats Fibroids Within the Cavity
Hysteroscopic myomectomy is performed through the cervix without an abdominal incision. It is generally used for fibroids located fully or partly within the uterine cavity.
The feasibility and complexity depend on:
- How much of the fibroid projects into the cavity
- How deeply it extends into the myometrium
- Size and number
- Location within the cavity
- Cervical access
- Surgeon experience
- Fluid-management and bleeding considerations
Some fibroids can be removed in one procedure. Larger or deeply embedded lesions may require staged treatment to protect the uterine wall and reduce risk.
Potential complications include bleeding, infection, fluid imbalance, uterine perforation, and intrauterine adhesions. These risks are not reasons to avoid appropriate treatment; they are reasons for careful selection, technique, and follow-up.
After removal, the cavity may need reassessment when the procedure was extensive or when adhesions are a concern. The timing of conception or embryo transfer should follow the operative findings rather than a standard message sent to every patient.
Laparoscopic or Open Myomectomy Treats Fibroids in the Uterine Wall
Intramural, subserosal, numerous, or very large fibroids may require laparoscopic, robotic, or open abdominal myomectomy.
The approach depends on fibroid size, number, depth, location, uterine anatomy, previous surgery, surgeon expertise, and the need to reconstruct the uterine wall safely.
The operation may involve:
- Significant blood loss
- Adhesion formation
- Entry into or proximity to the uterine cavity
- A uterine scar that affects future pregnancy planning
- A recovery period before conception or embryo transfer
- The small possibility that hysterectomy becomes necessary in a severe complication
Minimally invasive surgery can reduce recovery time in suitable cases, but the smallest incision is not the only measure of quality. Complete, controlled removal and careful uterine reconstruction may matter more than the label of the approach.
The patient should receive an operative report detailed enough for the future fertility and obstetric teams to understand what was removed and how the uterus was repaired.
Surgery Can Improve the Uterus and Still Delay the Opportunity
Myomectomy may create a more favourable uterine environment when the indication is sound. It also introduces time.
Time may be needed for:
- Preoperative correction of anaemia
- Surgical scheduling
- Recovery from the procedure
- Healing of the uterine wall
- Postoperative imaging or cavity review
- Management of complications if they occur
There is no single evidence-based waiting period that applies after every myomectomy. The recommended interval depends on the route of surgery, depth and number of uterine incisions, cavity entry, closure, healing, and the surgeon’s findings.
For a younger patient with reassuring ovarian reserve, this delay may be acceptable. For an older patient or someone with diminished reserve, the reproductive cost may be more significant.
The question is not only whether surgery could help. It is whether surgery should occur before egg collection, after embryos are created, or not at all.
Egg Collection Before Myomectomy May Be a Staged Option
When fertility time is limited but uterine surgery is likely to be needed before pregnancy, a staged plan may be considered:
- Complete ovarian stimulation and egg collection.
- Freeze eggs or embryos as appropriate.
- Perform myomectomy.
- Allow individualised healing and reassessment.
- Plan embryo transfer later.
This approach may preserve the age-related opportunity of the eggs while avoiding transfer into a cavity or uterus that requires treatment.
It is not suitable for every patient. Very large fibroids may make ovarian access, stimulation monitoring, anaesthesia, or egg collection technically difficult. Symptoms or medical risk may also require surgery first.
Staging should be chosen because it solves a defined timing problem—not because every fibroid patient needs two treatment pathways.
IVF Does Not Automatically Bypass the Uterus
IVF can overcome tubal obstruction, severe male factor, and other causes of infertility. It cannot make a cavity-distorting lesion irrelevant.
Creating a high-quality embryo does not remove the need for an appropriate uterine environment. If a fibroid materially changes the cavity, proceeding directly to transfer may use an embryo without first addressing a potentially correctable factor.
At the same time, IVF should not be postponed for every fibroid visible on ultrasound.
A useful decision separates egg collection from embryo transfer. It may be reasonable to proceed with ovarian stimulation while uterine planning continues, then freeze embryos and defer transfer. In another patient, no fibroid intervention may be needed.
The uterus and the ovaries share one treatment plan, but they do not always need to be treated on the same day.
Medical Treatment Can Control Symptoms but Does Not Remove the Fertility Decision
Hormonal medicines may reduce heavy bleeding and pain. Gonadotrophin-releasing hormone analogues or antagonists may temporarily shrink fibroids or improve blood counts before surgery in selected patients.
These treatments generally prevent conception while they are used, and fibroids may regrow after treatment ends. They are not a permanent fertility treatment.
Medication may be valuable as:
- Symptom control while pregnancy is deferred
- A bridge to surgery
- A way to correct anaemia
- Part of preparation for a technically difficult procedure
The expected benefit, side effects, duration, and effect on the fertility timeline should be explained.
Medical suppression should not become an indefinite delay in a patient whose primary goal is pregnancy.
Uterine Artery Embolisation and Other Procedures Need Fertility-Specific Counselling
Uterine artery embolisation reduces blood flow to fibroids so that they shrink. Other image-guided or energy-based procedures may also be offered for symptom control.
These approaches may be appropriate for selected patients, but future fertility and pregnancy require specific counselling because reproductive outcome data and uterine or ovarian effects differ from those of myomectomy.
For a patient actively planning pregnancy, the procedure should not be selected only because it offers a shorter immediate recovery. The discussion should include:
- Available evidence for future pregnancy
- Possible effects on the uterus and ovaries
- Risk of later intervention
- Obstetric considerations
- Alternative fertility-preserving treatments
Endometrial ablation is not a fertility-preserving treatment and is inappropriate for patients who wish to carry a future pregnancy.
The word “uterus-preserving” does not automatically mean “fertility-preserving.”
Pregnancy After Myomectomy Requires an Operative History
Pregnancy planning after myomectomy depends partly on how the uterus was operated on.
The obstetric team may need to know:
- Number, size, and location of fibroids removed
- Surgical route
- Depth and location of uterine incisions
- Whether the endometrial cavity was entered
- How the uterine wall was closed
- Complications or postoperative imaging
- The surgeon’s recommendation regarding conception and birth
Some patients may be advised to have planned caesarean birth because of the nature of the uterine scar; others may not require the same recommendation. The decision should be made from the operative details and obstetric assessment.
A future pregnancy should not depend on the patient remembering a verbal summary years later.
Fibroids During Pregnancy Need Proportionate Monitoring
Many patients with fibroids have uncomplicated pregnancies. Depending on size, location, and number, fibroids may also be associated with pain, bleeding, fetal position, placental problems, preterm birth, or delivery complications.
The presence of a fibroid does not predict that one of these outcomes will occur.
Obstetric care should document the fibroid burden, monitor clinically relevant findings, and manage symptoms or complications according to the pregnancy—not create anxiety through a list of every possible risk.
Fibroids are rarely removed during pregnancy because of bleeding and other operative risks, except in exceptional circumstances. Planning before pregnancy is therefore valuable when a fibroid already has a clear treatment indication.
International Patients Need a Decision Before a Travel Itinerary
A patient considering IVF or myomectomy abroad should have records reviewed before travel wherever possible.
Useful information may include:
- Recent ultrasound and original images
- Saline-sonography, hysteroscopy, or MRI reports
- Fibroid measurements and location
- Haemoglobin and iron studies when bleeding is heavy
- Previous operative and pathology reports
- Fertility tests and treatment history
- Pregnancy and miscarriage history
- Current symptoms and medication
Remote review may establish whether additional imaging, hysteroscopy, fertility treatment, or surgical consultation is needed. It may not determine the final surgical approach when examination or expert imaging is still required.
Travel duration should reflect the actual pathway. A brief hysteroscopic procedure and a complex abdominal myomectomy do not have the same recovery or follow-up needs.
The medical plan should determine the journey—not the other way around.
A Five-Part Decision Before Treatment
At Jinemed, the decision can be organised around five questions:
- Does the fibroid distort the uterine cavity?
- Does it cause symptoms or medical problems that require treatment?
- Is there evidence that removing this type of fibroid may improve the patient’s reproductive pathway?
- What risks, scar, adhesions, or delay would treatment create?
- Should egg collection occur before uterine intervention?
These questions may lead to observation, further imaging, hysteroscopic removal, laparoscopic or open myomectomy, staged IVF and surgery, or another individualised plan.
The plan should state the indication and the intended benefit. It should also identify what will happen if the fibroid is observed rather than treated.
When Treatment Helps—and When It Delays
Fibroid care in reproductive medicine is a decision about anatomy, evidence, symptoms, and time.
Treatment is more likely to help when a fibroid distorts the uterine cavity, causes significant symptoms, creates technical difficulty, or has another clear clinical indication. Treatment may delay without proven benefit when an incidental fibroid is removed simply because it is visible.
At Jinemed, neither surgery nor IVF is treated as the automatic answer.
The aim is to protect the uterine environment without sacrificing reproductive opportunity unnecessarily. Sometimes that means removing a fibroid before pregnancy. Sometimes it means collecting eggs first. Sometimes it means monitoring the fibroid and proceeding with treatment. And sometimes it means treating bleeding or pain even when fertility is not affected.
The best decision is not the one that removes the most fibroids. It is the one that improves the patient’s overall path with the least unnecessary cost to health, fertility, and time.